Outi Lahdenperä

- Docent,
Clinical Oncology (Department of Clinical Medicine)

outi.lahdenpera@utu.fi

Publications

Lymfactin® gene therapy with vascularized lymph node transfer reduces compression-free swelling and enhances quality of life in breast cancer-related lymphedema: Final Phase I trial results (2025)
- Journal of Plastic, Reconstructive and Aesthetic Surgery
Pajula, Susanna; Saarikko, Anne; Suominen, Sinikka; Kaartinen, Ilkka; Kiiski, Juha; Suominen, Erkki; Viitanen, Tiina; Mäki, Maija; Seppänen, Marko; Lahdenperä, Outi; Alitalo, Kari; Hartiala, Pauliina
(A1 Refereed original research article in a scientific journal)
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial (2022)
- Journal of Clinical Oncology
Joensuu Heikki, Kellokumpu-Lehtinen Pirkko-Liisa, Huovinen Riikka, Jukkola Arja, Tanner Minna, Ahlgren Johan, Auvinen Päivi, Lahdenperä Outi, Villman Kenneth, Nyandoto Paul, Nilsson Greger, Poikonen-Saksela Paula, Kataja Vesa, Bono Petri, Junnila Jouni, Lindman Henrik
(A1 Refereed original research article in a scientific journal)
Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema (2022)
- Journal of Plastic, Reconstructive and Aesthetic Surgery
Leppäpuska Ida-Maria, Hartiala Pauliina, Suominen Sinikka, Suominen Erkki, Kaartinen Ilkka, Mäki Maija, Seppänen Marko, Kiiski Juha, Viitanen Tiina, Lahdenperä Outi, Vuolanto Antti, Alitalo Kari, Saarikko Anne M.
(A1 Refereed original research article in a scientific journal)
High baseline Tie1 level predicts poor survival in metastatic breast cancer (2019)
- BMC Cancer
Leena Tiainen, Emilia A. Korhonen, Veli-Matti Leppänen, Tiina Luukkaala, Mari Hämäläinen, Minna Tanner, Outi Lahdenperä, Pia Vihinen, Arja Jukkola, Peeter Karihtala, Sonja Aho, Eeva Moilanen, Kari Alitalo, Pirkko-Liisa Kellokumpu-Lehtinen
(A1 Refereed original research article in a scientific journal)
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer (2019)
- Clinical Breast Cancer
Leena Tiainen, Mari Hämäläinen, Tiina Luukkaala, Minna Tanner, Outi Lahdenperä, Pia Vihinen, Arja Jukkola, Peeter Karihtala, Eeva Moilanen, Pirkko-Liisa Kellokumpu-Lehtinen
(A1 Refereed original research article in a scientific journal)
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer The Randomized Clinical FinXX Trial (2017)
- JAMA Oncology
Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Lahdenpera O, Kosonen S, Villman K, Nyandoto P, Nilsson G, Poikonen-Saksela P, Kataja V, Junnila J, Bono P, Lindman H
(A1 Refereed original research article in a scientific journal)
Bevacizumab combined with docetaxel or paclitaxel as first-line treatment of HER2-negative metastatic breast cancer (2016)
- Anticancer Research
Tiainen Leena, Tanner Minna, Lahdenperä Outi, Vihinen Pia, Jukkola Arja, Karihtala Peeter, Paunu Niina, Huttunen Teppo, Kellokumpu-Lehtinen Pirkko-Liisa
(A1 Refereed original research article in a scientific journal)
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX) (2014)
- Acta Oncologica
Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Saarni O, Helle L, Villman K, Nyandoto P, Nilsson G, Leinonen M, Kataja V, Bono P, Lindman H
(A1 Refereed original research article in a scientific journal)
Oral bioavailability of ospemifene improves with food intake (2013)
- International Journal of Clinical Pharmacology and Therapeutics
Koskimies P, Katila K, Lammintausta R, Aaltonen AM, Vuorinen J, Saarni O, Scheinin M
(A1 Refereed original research article in a scientific journal)